UNSPSC 85752422: Bypass left vas deferens to right vas deferens with nonautologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass left vas deferens to right vas deferens with nonautologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0V1P0KN

UNSPSC 85752422 Bypass left vas deferens to right vas deferens with nonautologous tissue substitute, open approach is a Commodity code assigned to medical and surgical procedure terminology; however, the code shows no recent state and local procurement activity aligned with its nominal scope. The source records six recent state and local opportunities posted between July and September 2026, none of which reflect the specific urological surgical procedure named in the code. Instead, the opportunities span occupational medical surveillance, independent medical evaluations for public safety retirement disability determinations, pharmacy benefit management, temporary health professional staffing, specialty surgical carve-out networks for municipal employee health plans, and emergency medical services procurement for juvenile detention facilities. These opportunities reflect administrative healthcare services, staffing, and benefit program management — domains far removed from procedural implants or surgical supplies.

The mismatch between the code's technical surgical nomenclature and the actual state and local buying activity under it signals that this Commodity code is either misapplied by issuing bodies in their procurement taxonomy, used only rarely for genuine orthopedic or urological implant purchases, or both. State and local procurement offices sourcing actual surgical implants, tissue substitutes, or procedure-specific devices typically issue specialized RFPs through health systems, hospital networks, or group purchasing agreements rather than general procurement portals. The recent opportunities under this code do not support a viable business development strategy targeting state and local surgical implant or tissue substitute procurement. Interested vendors should verify directly with health system procurement offices and group purchasing organizations rather than relying on this code's recent activity to surface opportunities.